Taiwanese (TAIEX) Growth Healthcare Stocks

UPDATED Nov 23, 2024

Discover Taiwanese Healthcare Growth Stocks that are on the TAIEX. Sorted by forecasted growth, these Healthcare Stocks have higher than expected earnings or sales growth compared to other companies.

85 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

4164

CHC Healthcare Group
NT$39.900.9%-34.6%NT$6.7bNT$49.00PE20.5xE68.3%5.0%

6782

Visco Vision
NT$205.50-0.7%5.4%NT$12.9bNT$268.20PE20.9xE20.7%1.2%

1565

St.Shine OpticalLtd
NT$229.50-2.8%18.6%NT$11.6bNT$261.00PE18.4xE18.4%3.1%

3218

Universal Vision Biotechnology
NT$215.501.9%-27.1%NT$18.3bNT$215.00PE16.9xE10.0%3.2%

6491

Pegavision
NT$373.500.9%-6.5%NT$29.1bNT$440.00PE14.6xE9.2%2.7%

4126

Pacific Hospital Supply
NT$89.00-0.3%6.0%NT$6.5bNT$96.00PE15.7xE5.6%5.4%

4104

Excelsior Medical
NT$87.001.0%5.2%NT$14.2bNT$85.71PE18.5xn/a4.2%

6543

Perfect Medical Industry
NT$26.001.6%42.5%NT$1.4bn/aPE19.5xn/a2.4%

1784

BIONET
NT$92.806.8%70.8%NT$4.7bn/aPE84.3xn/a0.7%

3118

Level Biotechnology
NT$32.100%5.6%NT$1.0bn/aPE15.9xn/a5.3%

6872

NaviFUS
NT$29.501.0%21.9%NT$1.7bn/an/an/an/a

4107

Bioteque
NT$128.001.2%18.0%NT$8.9bn/aPE17.8xn/a3.5%

1799

Easywell Biomedicals
NT$73.0010.6%79.8%NT$8.9bn/aPS24.6xn/an/a

4724

Meribank Biotech
NT$30.35-5.0%-21.9%NT$2.7bn/aPS10.2xn/an/a

7724

U-ARK Technology
NT$47.00-1.1%n/aNT$1.7bn/an/an/an/a

6734

iXensor
NT$4.621.3%-79.9%NT$101.4mn/aPS6xn/an/a

4150

Unicon Optical
NT$14.402.9%41.9%NT$2.1bn/aPE17.4xn/an/a

4197

Visgeneer
NT$9.470%-13.9%NT$285.8mn/aPS2.4xn/a0%

6762

Delta Asia International
NT$276.003.8%26.5%NT$8.4bn/aPE355.6xn/a0.06%

6918

Aplus Biotechnology
NT$81.900.9%80.4%NT$2.5bn/an/an/a3.3%

6815

Diamond Biotechnology
NT$71.90-5.6%-8.8%NT$2.4bn/aPE36.3xn/a0.2%

6612

ICARES Medicus
NT$125.50-3.5%7.9%NT$5.4bn/aPE81.8xn/a0.1%

6747

Brighten Optix
NT$137.50-1.8%-19.0%NT$3.7bn/aPE25xn/a3.5%

6130

Shangya Technology
NT$26.00-3.3%-28.0%NT$1.2bn/aPS5.6xn/a1.9%
Page 1 of 4
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.